Nevertheless, in this study the patients with SCLC transformation had a distinct mutational profile, which included TP53 and PIK3CA, already at baseline, suggesting PIK3CA might also play a role in this dedifferentiation [35]. Here, TP53 is linked to small cell lung carcinoma.